• Study of Venetoclax and Blinatumomab for Adults with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study Comparing FOLFOX Before Surgery to Risk-Adapted Chemotherapy After Surgery for Patients with Locally Advanced Rectal Cancer and Low Risk of Local Failure

    Not recruiting

    3 1 1 1
    Germany
  • Study of Setmelanotide for Patients with Obesity Due to Specific Genetic Variants

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece The Netherlands Spain
  • Study on Diarrhea Discontinuations in Early-stage HER2+ Breast Cancer Patients Treated with Neratinib, Loperamide, and Colesevelam

    Not recruiting

    2 1 1 1
    Croatia France Italy Spain
  • Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark France Germany +5
  • Study Comparing Sacituzumab Govitecan to Physician’s Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia France Germany Hungary +6
  • Study on Pembrolizumab for Patients with Localized Non-Metastatic MSI/dMMR Tumors or EBV+ Gastric Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study Comparing Tusamitamab Ravtansine and Docetaxel for Patients with Previously Treated Metastatic Non-Small Cell Lung Cancer with CEACAM5-Positive Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study on Long-Term Safety of Oral Lucerastat for Adults with Fabry Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Norway Poland +1
  • Study of hydrocortisone and fludrocortisone combination versus placebo in adults with sepsis in intensive care unit to determine corticosteroid response

    Not recruiting

    3 1 1
    Investigated Diseases:
    France

powered by